MedTrace Logo

The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU

NCT01609868 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-01-31

No results posted yet for this study

Summary

The investigators hypothesis that premature infants receiving a commercially available liquid protein modular will have improved growth when compared with premature infants receiving a commercially available powder protein modular.

Conditions

  • Problem With Growth of an Infant

Interventions

DIETARY_SUPPLEMENT

Powder protein modular

Infants will receive powder protein modular to achieve 4 grm/kg/day

DIETARY_SUPPLEMENT

Liquid protein modular

Infants will receive a commerically avaliable liquid protein modular to provide 4 grm/kg/day

Sponsors & Collaborators

  • Alegent Health Bergan Mercy Medical Center

    collaborator UNKNOWN

  • University of Nebraska

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
40 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01609868 on ClinicalTrials.gov